These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 16797734)

  • 1. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.
    Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K
    Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
    Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
    J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
    Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
    Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Chono K; Katsumata K; Suzuki H; Shiraki K
    Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
    Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
    Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine.
    Shiraki K; Ogino T; Yamamoto T; Yamanishi K; Takahashi M
    Biken J; 1986 Mar; 29(1):11-7. PubMed ID: 3022709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
    McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo.
    Kurokawa M; Hozumi T; Tsurita M; Kadota S; Namba T; Shiraki K
    J Pharmacol Exp Ther; 2001 Apr; 297(1):372-9. PubMed ID: 11259565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
    Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
    Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses.
    Sekiyama T; Hatsuya S; Tanaka Y; Uchiyama M; Ono N; Iwayama S; Oikawa M; Suzuki K; Okunishi M; Tsuji T
    J Med Chem; 1998 Apr; 41(8):1284-98. PubMed ID: 9548818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
    Morfin F; Frobert E; Thouvenot D
    Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses.
    Koch C; Reichling J; Kehm R; Sharaf MM; Zentgraf H; Schneele J; Schnitzler P
    J Pharm Pharmacol; 2008 Nov; 60(11):1545-50. PubMed ID: 18957177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
    Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus.
    Bohn K; Zell R; Schacke M; Wutzler P; Sauerbrei A
    Antivir Ther; 2011; 16(7):989-97. PubMed ID: 22024514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.